E-Book | February 16, 2023

Central IRB Review For Institutional Sites: A Toolkit For Sponsors And CROs

Source: Advarra
GettyImages-1445335845 regulatory

Having all sites use a central IRB builds efficiencies and results in significant resource savings for everyone involved in the research study and improves human subject protections. The benefits include:

  • Reduces the sponsor/CRO workload of managing submissions to multiple IRBs throughout the life of the study.
  • Reduces overall cost of study conduct.
  • Frees up institutional resources to focus on patient/subject care and managing training, audits, and other research-related activities.
  • Improves study activation time and recruitment, as a more efficient central IRB review process allows investigators to begin recruiting earlier and compete successfully with other study sites.
  • Creates more opportunities for institutional sites to conduct industry-sponsored research. Some sponsors will not work with, or will limit the number of, institutions who only accept local IRB review.
  • FDA and OHRP agree that centralized IRB review increases efficiencies and reduces duplication and administrative burden.
  • Improves human subject protection through consistent single IRB review and uniform subject information and study conduct (informed consent, recruitment materials, protocol information, etc.).

access the E-Book!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader